http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101940042-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-258 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101940042-B1 |
| titleOfInvention | A composition comprising an extract of Salvia pleia, and red ginseng, as an active ingredient for preventing or treating respiratory inflammation disease |
| abstract | The present invention relates to a composition for the prevention and treatment of respiratory inflammatory diseases, which comprises a combination extract comprising pale green cabbage and red ginseng as an active ingredient. Inhibiting the active oxygen species generated by the target combined extracts according to the invention Test (Test Example 1) a strong active oxygen inhibitory effect was confirmed indicates via, leukotrienes (leukotriene) generated inhibitory ability evaluation (Test Example 2) through was confirmed strong leukotrienes (leukotriene) generated indicates an inhibitory effect, a total of BAL fluid (BAL the ; bronchoalveolar lavage) cell count measurement experiment (Experiment 3) was confirmed strong BAL total cell number refers to reduction through the bronchial lavage fluid (BAL fluid) within the white blood cells (leukotcyte) of the CD11b + / Gr -1+ cell ratio measurement ( experiment 4) the strong CD11b + / Gr-1 + rate of leukocyte inhibition effect was confirmed by the indicated, intrapulmonary Cytokine (cytokine) effects on mRNA expression level experiment (Experiment 5) was confirmed by a strong inflammatory cytokines and inflammatory markers represent the level of expression inhibitory effect, bronchoalveolar lavage (BAL fluid) Effect on experimental inflammatory factor level of expression (Example 6) has confirmed that the strong inflammatory cytokines and inflammatory markers represent the expression level of inhibitory effect through, through the effect experiments on lung tissue changes (Example 7) The closed-cell wall thinning was confirmed that the decrease in collagen fibers, In particular, by confirming that synergistic bronchial inflammation is suppressed or therapeutic effect upon administration of the combination extract of the present invention, it can be safely used for the prevention or treatment of respiratory inflammatory diseases by confirming the powerful therapeutic effect on respiratory inflammatory diseases . |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102112287-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220078816-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102240432-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102245147-B1 |
| priorityDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 384.